BIO IP Counsels Committee Conference
November 14-16, 2018
Indianapolis, IN
Biotechnology Innovation Organization (BIO)
Finnegan is a sponsor of the BIO IP Counsels Committee Conference, hosted by the Biotechnology Innovation Organization. Finnegan partners Howard Levine and Alissa Lipton will join the panel discussion “Obviousness-Type Double Patenting—Where Are We, and Is It Time for a Legislative Clarification?” and Howard Levine and Amanda Murphy will join the panel discussion “The Role of CRISPR in Agricultural, Industrial, and Medical Biotechnology—What Every Patent Practitioner Should Know.” The program will take place at the Conrad Hotel in Indianapolis, Indiana. For more information, or to register, please see BIO’s website.
